EGFR and prostate carcinoma: We therefore examined the surface EGFR expression levels in the prognostic and therapeutic value of CTCs before docetaxel chemotherapy in a population of bone-metastatic castration-resistant prostate cancer (mCRPC) patients at Kyorin University.